User profiles for Aleksandra Leligdowicz
Aleksandra LeligdowiczUniversity of Western Ontario, Robarts Research Institute Verified email at uwo.ca Cited by 3438 |
[HTML][HTML] Redefining critical illness
Research and practice in critical care medicine have long been defined by syndromes,
which, despite being clinically recognizable entities, are, in fact, loose amalgams of …
which, despite being clinically recognizable entities, are, in fact, loose amalgams of …
[HTML][HTML] Intensive care unit capacity in low-income countries: a systematic review
S Murthy, A Leligdowicz, NKJ Adhikari - PloS one, 2015 - journals.plos.org
Purpose Access to critical care is a crucial component of healthcare systems. In low-income
countries, the burden of critical illness is substantial, but the capacity to provide care for …
countries, the burden of critical illness is substantial, but the capacity to provide care for …
[HTML][HTML] Heterogeneity in sepsis: new biological evidence with clinical applications
A Leligdowicz, MA Matthay - Critical care, 2019 - Springer
This article is one of ten reviews selected from the Annual Update in Intensive Care and
Emergency Medicine 2019. Other selected articles can be found online at https://www.…
Emergency Medicine 2019. Other selected articles can be found online at https://www.…
[HTML][HTML] Global absence and targeting of protective immune states in severe COVID-19
Although infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
pleiotropic and systemic effects in some individuals 1 , 2 – 3 , many others experience …
pleiotropic and systemic effects in some individuals 1 , 2 – 3 , many others experience …
Association between source of infection and hospital mortality in patients who have septic shock
A Leligdowicz, PM Dodek, M Norena… - American journal of …, 2014 - atsjournals.org
Rationale: Mortality caused by septic shock may be determined by a systemic inflammatory
response, independent of the inciting infection, but it may also be influenced by the anatomic …
response, independent of the inciting infection, but it may also be influenced by the anatomic …
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis
…, KN Kangelaris, A Sarma, A Leligdowicz… - The lancet respiratory …, 2022 - thelancet.com
Background Two acute respiratory distress syndrome (ARDS) subphenotypes (hyperinflammatory
and hypoinflammatory) with distinct clinical and biological features and differential …
and hypoinflammatory) with distinct clinical and biological features and differential …
[HTML][HTML] Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS
The immunological features that distinguish COVID-19-associated acute respiratory distress
syndrome (ARDS) from other causes of ARDS are incompletely understood. Here, we report …
syndrome (ARDS) from other causes of ARDS are incompletely understood. Here, we report …
[HTML][HTML] Endothelial activation: the Ang/Tie axis in sepsis
A Leligdowicz, M Richard-Greenblatt, J Wright… - Frontiers in …, 2018 - frontiersin.org
Sepsis, a dysregulated host response to infection that causes life-threatening organ dysfunction,
is a highly heterogeneous syndrome with no specific treatment. Although sepsis can be …
is a highly heterogeneous syndrome with no specific treatment. Although sepsis can be …
[HTML][HTML] Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS
KD Wick, A Leligdowicz, H Zhuo, LB Ware… - JCI insight, 2021 - ncbi.nlm.nih.gov
BACKGROUND Whether airspace biomarkers add value to plasma biomarkers in studying
acute respiratory distress syndrome (ARDS) is not well understood. Mesenchymal stromal …
acute respiratory distress syndrome (ARDS) is not well understood. Mesenchymal stromal …
Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials
…, KN Kangelaris, A Sarma, A Leligdowicz… - The Lancet …, 2023 - thelancet.com
Background In sepsis and acute respiratory distress syndrome (ARDS), heterogeneity has
contributed to difficulty identifying effective pharmacotherapies. In ARDS, two molecular …
contributed to difficulty identifying effective pharmacotherapies. In ARDS, two molecular …